Drug Targets Hard-to-Reach Leukemia Stem Cells Responsible for Relapses

... principal investigator Catriona H. M. Jamieson, MD, PhD, associate professor of medicine and director of stem cell research at UC San Diego Moores Cancer Center, the researchers found that a compound called sabutoclax appears to selectively target ...

http://ucsdnews.ucsd.edu/pressreleases/drug_targets_hard-to-reach_leukemia_stem_cells_responsible_for_relapses